References

Publication Details

  1. Albritton L.M., Tseng L., Scadden D., Cunningham J.M. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell. 1989;57:659–666. [PubMed: 2541919]
  2. Aloia R.C., Tian H., Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. 1993;90:5181–5185. [PMC free article: PMC46679] [PubMed: 8389472]
  3. Arthur L.O., Bess J.W. Jr., Sowder R.C. II, Benveniste R.E., Mann D.L., Chermann J.C., Henderson L.E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 1992;258:1935–1938. [PubMed: 1470916]
  4. Arthur L.O., Bess J.W.J., Urban R.G., Strominger J.L., Morton W.R., Mann D.L., Henderson L.E., Benveniste R.E. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J. Virol. 1995;69:3117–3124. [PMC free article: PMC189013] [PubMed: 7707540]
  5. Arts E.J., Mak J., Kleiman L., Wainberg M.A. DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity. J. Gen. Virol. 1994;75:1605–1613. [PubMed: 7517431]
  6. August J.T., Bolognesi D.P., Fleissner E., Gilden R.V., Nowinski R.C. A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology. 1974;60:595–601. [PubMed: 4135911]
  7. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature. 1970;226:1209–1211. [PubMed: 4316300]
  8. Baltimore D. Tumor viruses: 1974. Cold Spring Harbor Symp. Quant. Biol. 1975;39:1187–1200. [PubMed: 50896]
  9. Barbacid M., Aaronson S.A. Membrane properties of the gag gene-coded p15 protein of mouse type-C RNA tumor viruses. J. Biol. Chem. 1978;253:1408–1414. [PubMed: 627545]
  10. Beemon K.L., Keith J. Localizaton of N6-methyladenosine in the Rous sarcoma virus genome. J. Mol. Biol. 1977;113:165–179. [PubMed: 196091]
  11. Beemon K.L., Duesberg P., Vogt P. Evidence for crossing-over between avian tumor viruses based on analysis of viral RNAs. Proc. Natl. Acad. Sci. 1974;71:4254–4258. [PMC free article: PMC434370] [PubMed: 4372615]
  12. Bender W., Davidson N. Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell. 1976;7:595–607. [PubMed: 182376]
  13. Berberich S.L., Stoltzfus C.M. Mutations in the regions of the Rous sarcoma virus 3′ splice sites: Implications for regulation of alternative splicing. J. Virol. 1991;65:2640–2646. [PMC free article: PMC240622] [PubMed: 1850037]
  14. Berkowitz R.D., Fisher J., Goff S.P. RNA packaging. Curr. Top. Microbiol. Immunol. 1996;214:177–218. [PubMed: 8791728]
  15. Berkowitz R.D., Luban J., Goff S.P. Specific binding of human immunodeficiency virus type 1 Gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 1993;67:7190–7200. [PMC free article: PMC238181] [PubMed: 8230441]
  16. Berkowitz R.D., Ohagen A., Höglund S., Goff S.P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 1995;69:6445–6456. [PMC free article: PMC189545] [PubMed: 7666546]
  17. Bernhard W. Electron microscopy of tumor cells and tumor viruses: A review. Cancer Res. 1958;18:491–509. [PubMed: 13547041]
  18. Bernstein H.B., Compans R.W. Sulfation of the human immunodeficiency virus envelope glycoprotein. J. Virol. 1992;66:6953–6959. [PMC free article: PMC240329] [PubMed: 1433500]
  19. Bernstein H.B., Tucker S.P., Hunter E., Schutzbach J.S., Compans R.W. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 1994;68:463–468. [PMC free article: PMC236307] [PubMed: 8254757]
  20. Bess J.W. Jr., Powell P.J., Issaq H.J., Schumack L.J., Grimes M.K., Henderson L.E., Arthur L.O. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses. J. Virol. 1992;66:840–847. [PMC free article: PMC240784] [PubMed: 1731111]
  21. Best S., LeTissier P., Towers G., Stoye J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature. 1996;382:826–829. [PubMed: 8752279]
  22. Bieth E., Gabus C., Darlix J.-L. A study of the dimer formation of Rous sarcoma virus RNA and its effect of protein synthesis in vitro. Nucleic Acids Res. 1990;18:119–128. [PMC free article: PMC330211] [PubMed: 2155394]
  23. Billeter M.A., Parsons J.T., Coffin J.M. The nucleotide sequence complexity of avian tumor virus RNA. Proc. Natl. Acad. Sci. 1974;71:3560–3564. [PMC free article: PMC433814] [PubMed: 4372625]
  24. Bolognesi D.P., Montelaro R.C., Frank H., Schafer W. Assembly of type-C oncornaviruses: A model. Science. 1978;199:183–186. [PubMed: 202022]
  25. Bowerman B., Brown P.O., Bishop J.M., Varmus H.E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 1989;3:469–478. [PubMed: 2721960]
  26. Braaten D., Franke E.K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 1996;70:3551–3560. [PMC free article: PMC190230] [PubMed: 8648689]
  27. Bray M., Prasad S., Dubay J.W., Hunter E., Jeang K.T., Rekosh D., Hammarskjold M.L. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. 1994;91:1256–1260. [PMC free article: PMC43136] [PubMed: 8108397]
  28. Brody B.A., Rhee S.S., Hunter E. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 1994;68:4620–4627. [PMC free article: PMC236389] [PubMed: 8207836]
  29. Brody B.A., Rhee S.S., Sommerfelt M.A., Hunter E. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc. Natl. Acad. Sci. 1992;89:3443–3447. [PMC free article: PMC48884] [PubMed: 1565636]
  30. Brown P.O., Bowerman B., Varmus H.E., Bishop J.M. Correct integration of retroviral DNA in vitro. Cell. 1987;49:347–356. [PubMed: 3032450]
  31. Bryant M., Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. 1990;87:523–527. [PMC free article: PMC53297] [PubMed: 2405382]
  32. Bukrinsky M.I., Sharova N., McDonald T.L., Pushkarskaya T., Tarpley W.G., Stevenson M. Association of integrase, matrix and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. 1993a;90:6125–6129. [PMC free article: PMC46880] [PubMed: 7687060]
  33. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubel A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of nondividing cells. Nature. 1993b;365:666–670. [PMC free article: PMC9524217] [PubMed: 8105392]
  34. Burns N.R., Craig S., Lee S.R., Richardson S.M.H., Stenner M., Adams S.E., Kingsman S.M., Kingsman A.J. Purification and secondary structure determination of simian immunodeficiency virus p27. J. Mol. Biol. 1990;216:207–211. [PubMed: 2254920]
  35. Burstein H., Bizub D., Skalka A.M. Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers. J. Virol. 1991;65:6165–6172. [PMC free article: PMC250303] [PubMed: 1656090]
  36. Campbell S., Vogt V.M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 1995;69:6487–6497. [PMC free article: PMC189550] [PubMed: 7666550]
  37. Canaani E., Duesberg P.H. Role of subunits of 60 to 70S avian tumor virus ribonucleic acid in its template activity for the viral doxyribonucleic acid polymerase. J. Virol. 1972;10:23–31. [PMC free article: PMC356421] [PubMed: 4339194]
  38. Chance M.R., Sagi I., Wirt M.D., Frisbie S.M., Scheuring E., Chen E., Bess J.W. Jr., Henderson L.E., Arthur L.O., South T.L., Perez-Alvarado G., Summer M.F. Extended X-ray absorption fine structure studies of a retrovirus: Equine infectious anemia virus cysteine arrays are coordinated to zinc. Proc. Natl. Acad. Sci. 1992;89:10041–10045. [PMC free article: PMC50273] [PubMed: 1332027]
  39. Cheng R.H., Kuhn R.J., Olson N.H., Rossmann M.G., Choi H.-K., Smith T.J., Baker T.S. Nucleocapsid and glycoprotein organization in an enveloped virus. Cell. 1995;80:621–630. [PMC free article: PMC4167723] [PubMed: 7867069]
  40. Choi H.-K., Tong L., Minor W., Dumas P., Boege U., Rossmann M.G., Wengler C. Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature. 1991;354:37–43. [PubMed: 1944569]
  41. Ciechanover A. The ubiquitin-proteosome proteolytic pathway. Cell. 1994;79:13–21. [PubMed: 7923371]
  42. Coffin J.M. 1992Structure and classification of retroviruses In The Retroviridae (ed. J.A. Levy), vol. 1, pp. 19–50. Plenum Press, New York.
  43. Coffin J.M. 1996Retroviridae and their replication In Virology (ed. B.N. Fields et al.), pp. 1767–1848. Raven Press, New York.
  44. Coffin J.M., Billeter M.A. A physical map of the Rous sarcoma virus genome. J. Mol. Biol. 1976;100:293–318. [PubMed: 176365]
  45. Cohen E.A., Subbramanian R.A., Göttlinger H.G. Role of auxiliary proteins in retroviral morphogenesis. Curr. Top. Microbiol. Immunol. 1996;214:219–236. [PubMed: 8791729]
  46. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus Vpr product is a virion-associated regulatory protein. J. Virol. 1990;64:3097–3099. [PMC free article: PMC249501] [PubMed: 2139896]
  47. Craigie R., Fujiwara T., Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell. 1990;62:829–837. [PubMed: 2167180]
  48. Craven R.C., Leure-duPree A.E., Weldon R.A. Jr., Wills J.W. Genetic analysis of the major homology region of Rous sarcoma virus Gag protein. J. Virol. 1995;69:4213–4227. [PMC free article: PMC189159] [PubMed: 7769681]
  49. Craven R.C., Leure-duPree A.E., Erdie C.R., Wilson C.B., Wills J.W. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus Gag protein. J. Virol. 1993;67:6246–6252. [PMC free article: PMC238047] [PubMed: 8396679]
  50. Dahlberg J.E., Sawyer R.C., Taylor J.M., Faras A.J., Levinson W.E., Goodman H.M., Bishop J.M. Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer. J. Virol. 1974;13:1126–1133. [PMC free article: PMC355423] [PubMed: 4132919]
  51. Dalgleish A.G., Beverly P.C.L., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312:763–767. [PubMed: 6096719]
  52. Damsky C.H., Sheffield J.B., Tusznski G.P., Warren L. Is there a role for actin in virus budding? J. Cell Biol. 1977;75:593–605. [PMC free article: PMC2109946] [PubMed: 233748]
  53. Dannull J., Surovoy A., Jung G., Moelling K. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic residues. EMBO J. 1994;13:1525–1533. [PMC free article: PMC394981] [PubMed: 8156990]
  54. Davies D.R. The structure and function of the aspartic proteinases. Annu. Rev. Biophys. Biophys. Chem. 1990;19:189–215. [PubMed: 2194475]
  55. Davis N.L., Rueckert R.R. Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus. J. Virol. 1972;10:1010–1020. [PMC free article: PMC356572] [PubMed: 4344250]
  56. Dedera D.A., Gu R., Ratner L. Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function. Virology. 1992;187:377–382. [PubMed: 1736542]
  57. deHarven E. Remarks on the ultrastructure of type A, B, and C virus particles. Adv. Virus Res. 1974;19:221–264. [PubMed: 4374071]
  58. Demene H., Julian N., Morellet N., de Rocquigny H., Cornille F., Maigret B., Roques B.P. Three-dimensional 1H-NMR structure of the nucleocapsid protein NCp10 of Moloney murine leukemia virus. J. Biomol. NMR. 1994;4:153–170. [PubMed: 8019131]
  59. deRocquigny H., Gabus C., Vincent A., Fournie-Zaluski M.C., Roques B.P., Darlix J.-L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. 1992;89:6472–6476. [PMC free article: PMC49523] [PubMed: 1631144]
  60. de Thé G., Becker C., Beard J.W. Virus of avian myeloblastosis (BAI strain A). XXV. Ultrastructural study of virus and myeloblast phosphatase activity. J. Natl. Cancer Inst. 1964;32:201–235. [PubMed: 14114969]
  61. Dimock K., Stoltzfus C.M. Sequence specificity of internal methylation in B77 avian sarcoma virus RNA subunits. Biochemistry. 1977;16:471–448. [PubMed: 189800]
  62. Dong J., Roth M.G., Hunter E. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 1992;66:7374–7382. [PMC free article: PMC240443] [PubMed: 1331528]
  63. Doolittle R.F., Feng D.F., Johnson M.S., McClure M.A. Origins and evolutionary relationships of retroviruses. Q. Rev. Biol. 1989;64:1–30. [PubMed: 2469098]
  64. Doolittle R.F., Feng D.F., McClure M.A., Johnson M.S. 1990Retrovirus phylogeny and evolution In Retroviruses:Strategies of replication (ed. R. Swanstrom and P.K. Vogt), pp. 1–18. Springer-Verlag, New York. [PubMed: 2203607]
  65. Dorfman T., Mammano F., Haseltine W.A., Göttlinger H.G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 1994a;68:1689–1696. [PMC free article: PMC236628] [PubMed: 8107229]
  66. Dorfman T., Bukovsky A., Ohagen A., Höglund S., Göttlinger H.G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 1994b;68:8180–8187. [PMC free article: PMC237283] [PubMed: 7966609]
  67. Dorfman T., Luban J., Goff S.P., Haseltine W.A., Göttlinger H.G. Mapping of functionally important residues of a cysteinehistidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1993;67:6159–6169. [PMC free article: PMC238038] [PubMed: 8371356]
  68. Dorner A.J., Coffin J.M. Determinants for receptor interaction and cell killing of the avian retrovirus glycoprotein gp85. Cell. 1986;45:365–374. [PubMed: 3009025]
  69. Dougherty W.G., Semler B.L. Expression of virus-encoded proteinases: Functional and structural similarities with cellular enzymes. Microbiol. Rev. 1993;57:781–822. [PMC free article: PMC372939] [PubMed: 8302216]
  70. Duesberg P.H. Physical properties of Rous sarcoma virus RNA. Proc. Natl. Acad. Sci. 1968;60:1511–1518. [PMC free article: PMC224948] [PubMed: 4299948]
  71. Duesberg P.H., Martin G.S., Vogt P.K. Glycoprotein components of avian and murine RNA tumor viruses. Virology. 1970;41:631–646. [PubMed: 4319782]
  72. Durbin R.K., Manning J.S. The core of murine leukemia virus requires phosphate for structural stability. Virology. 1982;116:31–39. [PubMed: 7064343]
  73. Dyda F., Hickman A.B., Jenkins T.M., Engelman A., Craigie R., Davies D.R. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science. 1994;266:1981–1986. [PubMed: 7801124]
  74. Edwards S.A., Fan H. gag-Related polyproteins of Moloney murine leukemia virus: Evidence for independent synthesis of glycosylated and unglycosylated forms. J. Virol. 1979;30:551–563. [PMC free article: PMC353359] [PubMed: 469993]
  75. Edwards S.A., Fan H. Sequence relationship of glycosylated and unglycosylated gag polyproteins of Moloney murine leukemia virus. J. Virol. 1980;35:41–51. [PMC free article: PMC288781] [PubMed: 6997511]
  76. Ehrlich L.S., Agresta B.E., Carter C.A. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 1992;66:4874–4883. [PMC free article: PMC241323] [PubMed: 1629958]
  77. Ehrlich L.S., Agresta B.E., Gelfand C.A., Jentoft J., Carter C.A. Spectral analysis and tryptic susceptibility as probes of HIV-1 capsid protein structure. Virology. 1994;204:515–525. [PubMed: 7941318]
  78. Elder J.H., Lerner D.L., Hasselkus-Light C.S., Fontenot D.J., Hunter E., Luciw P.A., Montelaro R.C., Phillips T.R. Distinct subsets of retroviruses encode dUTPase. J. Virol. 1992;66:1791–1794. [PMC free article: PMC240941] [PubMed: 1310783]
  79. Emi N., Friedmann T., Yee J.-K. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 1991;65:1202–1207. [PMC free article: PMC239887] [PubMed: 1847450]
  80. Erickson E., Erickson R.L. Isolation of amino acid acceptor RNA from purified avian myeloblastosis virus. J. Mol. Biol. 1970;52:387–390. [PubMed: 4320940]
  81. Fäcke M., Janetzko A., Shoeman R.L., Kräusslich H.G. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 1993;67:4972–4980. [PMC free article: PMC237885] [PubMed: 8331736]
  82. Fan H., Baltimore D. RNA metabolism of murine leukemia virus: Detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA. J. Mol. Biol. 1973;80:93–117. [PubMed: 4798989]
  83. Felkner R.H., Roth M.J. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J. Virol. 1992;66:4258–4264. [PMC free article: PMC241230] [PubMed: 1318404]
  84. Feng Y.X., Fu W., Winter A.J., Levin J.G., Rein A. Multiple regions of Harvey sarcoma virus RNA can dimerize in vitro. J. Virol. 1995;69:2486–2490. [PMC free article: PMC188924] [PubMed: 7884897]
  85. Fleissner E., Tress E. Isolation of a ribonucleoprotein structure from oncornaviruses. J. Virol. 1973;12:1612–1615. [PMC free article: PMC356805] [PubMed: 4128388]
  86. Franke E.K., Yuan H.E.H., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 1994a;372:359–362. [PubMed: 7969494]
  87. Franke E.K., Yuan H.E.H., Bossolt K.L., Goff S.P., Luban J. Specificity and sequence requirements for interactions between various retroviral gag proteins. J. Virol. 1994b;68:5300–5305. [PMC free article: PMC236479] [PubMed: 8035530]
  88. Fu W., Rein A. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 1993;67:5443–5449. [PMC free article: PMC237946] [PubMed: 8350405]
  89. Fu W., Gorelick R.J., Rein A. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J. Virol. 1994;68:5013–5018. [PMC free article: PMC236443] [PubMed: 8035501]
  90. Fu X.D., Katz R.A., Skalka A.M. Site-directed mutagenesis of the avian retrovirus nucleocapsid protein pp12: Mutation which affects RNA binding in vitro blocks viral replication. J. Biol. Chem. 1988;263:2134–2139. [PubMed: 2828360]
  91. Fuller S.D., Berriman J.A., Butcher S.J., Gowen B.E. Low pH induces swiveling of the glycoprotein heterodimers in the Semliki forest virus spike complex. Cell. 1995;81:715–725. [PubMed: 7774013]
  92. Furuichi Y., Shatkin A.J., Stavnezer E., Bishop J.M. Blocked, methylated 5′ terminal sequence in avian sarcoma virus RNA. Nature. 1975;257:618–620. [PubMed: 170541]
  93. Gabuzda D.H., Lawrence K., Langhoff E., Terwilliger E.F., Dorfman T., Haseltine W.A., Sodroski J. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 1992;66:6489–6495. [PMC free article: PMC240141] [PubMed: 1357189]
  94. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 1995a;80:379–388. [PubMed: 7859280]
  95. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 1995b;83:569–576. [PubMed: 7585960]
  96. Gamble T.R., Vajdos F., Yoo S., Worthylake D.K., Houseweart J., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 1996;87:1285–1294. [PubMed: 8980234]
  97. Garcia J.V., Alfano J., Miller A.D. The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species-specific and requires the cytoplasmic domain of CD4. J. Virol. 1993;67:1511–1516. [PMC free article: PMC237521] [PubMed: 8437228]
  98. Gebhardt A., Bosch J.V., Ziemiecki A., Friis R.R. Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes: An insight into viral association. J. Mol. Biol. 1984;174:297–317. [PubMed: 6325711]
  99. Gelderblom H.R. Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS. 1991;5:617–638. [PubMed: 1652977]
  100. Gesteland R.F., Atkins J.F. 1993 The RNA world Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  101. Gillespie D., Marshall S., Gallo R.C. RNA of RNA tumour viruses contains poly A. Nat. New Biol. 1972;236:227–231.
  102. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 1996;273:231–235. [PubMed: 8662505]
  103. Gonzalez S.A., Affranchino J.L., Gelderblom H.R., Burny A. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology. 1993;194:548–556. [PubMed: 8503172]
  104. Gorelick R.J., Henderson L.E., Hanser J.P., Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: Evidence for specific RNA recognition by a zinc finger-like protein sequence. Proc. Natl. Acad. Sci. 1988;85:8420–8424. [PMC free article: PMC282469] [PubMed: 3141927]
  105. Göttlinger H.G., Sodroski J.G., Haseltine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. 1989;86:5781–5785. [PMC free article: PMC297714] [PubMed: 2788277]
  106. Göttlinger H.G., Dorfman T., Cohen E., Haseltine W.A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. 1993;90:7381–7385. [PMC free article: PMC47141] [PubMed: 8346259]
  107. Göttlinger H.G., Dorfman T., Sodroski J.G., Haseltine W.A. Effect of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. 1991;88:3195–3199. [PMC free article: PMC51412] [PubMed: 2014240]
  108. Grand R.J.A. Acylation of viral and eukaryotic proteins. Biochem. J. 1989;258:625–638. [PMC free article: PMC1138413] [PubMed: 2658970]
  109. Grandgenett D.P., Vora A.C., Schiff R.D. A 32,000 dalton nucleic acid binding protein from avian retrovirus cores possesses DNA endonuclease activity. Virology. 1978;89:119–132. [PubMed: 210568]
  110. Guarino L.A., Smith G., Dong W. Ubiquitin is attached to membranes of baculovirus particles by a novel type of phospholipid anchor. Cell. 1995;80:301–309. [PubMed: 7834750]
  111. Hayward W.S. Size and genetic content of viral RNAs in avian oncovirus-infected cells. J. Virol. 1977;24:47–63. [PMC free article: PMC515909] [PubMed: 198585]
  112. Heinzinger N.K., Bukrinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. 1994;91:7311–7315. [PMC free article: PMC44389] [PubMed: 8041786]
  113. Henderson L.E., Krutzsch H.C., Oroszlan S. Myristyl amino terminal acylation of murine retrovirus proteins: An unusual post translational protein modification. Proc. Natl. Acad. Sci. 1983;80:339–443. [PMC free article: PMC393372] [PubMed: 6340098]
  114. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., Sundquist W.I. Crystal structures of the trimeric HIV-1 matrix protein: Implications for membrane association and assembly. Proc. Natl. Acad. Sci. 1996;93:3099–3104. [PMC free article: PMC39768] [PubMed: 8610175]
  115. Hizi A., Henderson L.E., Copeland T.D., Sowder R.C., Krutzsch H.C., Oroszlan S. Analysis of Gag proteins from mouse mammary tumor virus. J. Virol. 1989;63:2543–2549. [PMC free article: PMC250722] [PubMed: 2542570]
  116. Holzschu D.L., Martineau D., Fodor S.K., Vogt V.M., Bowser P.R., Casey J.W. Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus. J. Virol. 1995;69:5320–5331. [PMC free article: PMC189371] [PubMed: 7636975]
  117. Höglund S., Öhagen A., Laurence K., Gabuzda D. Role of vif during packing of the core of HIV-1. Virology. 1994;201:349–355. [PubMed: 8184544]
  118. Höglund S., Öfverstedt L.G., Nilsson A., Lundquist P., Gelderblom H., Özel M., Skoglund U. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res. Hum. Retroviruses. 1992;8:1–7. [PubMed: 1736937]
  119. Huang A.S., Besmer P., Chu L., Baltimore D. Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J. Virol. 1973;12:659–662. [PMC free article: PMC356675] [PubMed: 4355863]
  120. Huang M., Orenstein J.M., Martin M.A., Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 1995;69:6810–6818. [PMC free article: PMC189593] [PubMed: 7474093]
  121. Hughes S.E., Shank P.R., Spector D.H., Kung H.-J., Bishop J.M., Varmus H.E., Vogt P.K., Breitman M.L. Proviruses of avian sarcoma virus are terminally redundant, coextensive with unintegrated linear DNA and integrated at many sites. Cell. 1978;15:1397–1410. [PubMed: 215325]
  122. Jacks T., Varmus H.E. Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science. 1985;230:1237–1242. [PubMed: 2416054]
  123. Jacobo-Molina A., Ding J., Nanni R.G., Clark A.D.J., Lu X., Tantillo C., Williams R.L., Kamer G., Ferris A.L., Clark P., Hizi A., Hughes S.H., Arnold E. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. 1993;90:6320–6324. [PMC free article: PMC46920] [PubMed: 7687065]
  124. Jaskólski M., Miller M., Rao J.K.M., Leis J., Wlodawer A. Structure of the aspartic protease from Rous sarcoma retrovirus refined at 1 Å resolution. Biochemistry. 1990;29:5889–5898. [PubMed: 2166563]
  125. Jamjoon G., Karshin W.I., Naso R.B., Arcement L.J., Arlinghaus R.B. Proteins of Rauscher murine leukemia virus: Resolution of a 70,000 dalton, nonglycosylated polypeptide containing p30 peptide sequences. Virology. 1975;68:135–145. [PubMed: 1189292]
  126. Jolicoeur P. The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top. Microbiol. Immunol. 1979;86:67–122. [PubMed: 227645]
  127. Kalpana G.V., Marmon S., Wang W., Crabtree G.R., Goff S.P. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science. 1994;266:2002–2006. [PubMed: 7801128]
  128. Katoh I., Kyushiki H., Sakamoto Y., Ikawa Y., Yoshinaka Y. Bovine leukemia virus matrix-associated protein MA (p15): Further processing and formation of a specific complex with the dimer of the 5′-terminal genomic RNA fragment. J. Virol. 1991;65:6845–6855. [PMC free article: PMC250779] [PubMed: 1658378]
  129. Katz R.A., Skalka A.M. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell. Biol. 1990;10:696–704. [PMC free article: PMC360868] [PubMed: 2153921]
  130. Katz R.A. The retroviral enzymes. Annu. Rev. Biochem. 1994;63:133–173. [PubMed: 7526778]
  131. Katz R.A., Merkel G., Kulkosky J., Leis J., Skalka A.M. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell. 1990;63:87–95. [PubMed: 2170022]
  132. Keith J., Fraenkel-Conrat H. Identification of the 5′ end of Rous sarcoma virus RNA. Proc. Natl. Acad. Sci. 1975;72:3347–3350. [PMC free article: PMC432989] [PubMed: 171660]
  133. Kim A., Terzian C., Santamaria P., Pelisson A., Prud'homme N., Bucheton A. Retroviruses in invertebrates: The gypsy retrotransposon is apparently an infectious retrovirus of Drosophila melanogaster. Proc. Natl. Acad. Sci. 1994;91:1285–1289. [PMC free article: PMC43142] [PubMed: 8108403]
  134. Klikova M., Rhee S.S., Hunter E., Ruml T. Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria. J. Virol. 1995;69:1093–1098. [PMC free article: PMC188681] [PubMed: 7815488]
  135. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., Steitz T.A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992;256:1783–1790. [PubMed: 1377403]
  136. Kondo E., Mammano F., Cohen E.A., Göttlinger H.G. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 1995;69:2759–2764. [PMC free article: PMC188969] [PubMed: 7707498]
  137. Konvalinka J., Löchelt M., Zentgraf H., Flügel R.M., Kräusslich H.-G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J. Virol. 1995;69:7264–7268. [PMC free article: PMC189650] [PubMed: 7474150]
  138. Kräusslich H.-G. Human immunodeficiency virus proteinase dimer as a component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. 1991;88:3213–3217. [PMC free article: PMC51416] [PubMed: 2014242]
  139. Kräusslich H.-G., Fäcke M., Heuser A.M., Konvalinka J., Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 1995;69:3407–3419. [PMC free article: PMC189053] [PubMed: 7745687]
  140. Lai M.M.C. Phosphoproteins of Rous sarcoma viruses. Virology. 1976;74:287–301. [PubMed: 185795]
  141. Lai M.M.C., Duesberg P.H. Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature. 1972;235:383–386. [PubMed: 4334604]
  142. Lapatto R., Blundell T., Hemmings A., Overington J., Wilderspin A., Wood S., Merson J.R., Whittle P.J., Danley D.E., Geoghegan K.F., Hawryklik S.J., Lee S.E., Scheld K.G., Hobart P.M. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature. 1989;342:299–302. [PubMed: 2682266]
  143. Le Grice S.F.J., Naas T., Wohlgensinger B., Schatz O. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer associated p51 of HIV-1 reverse transcriptase. EMBO J. 1991;10:3905–3911. [PMC free article: PMC453128] [PubMed: 1718745]
  144. Leis J., Baltimore D., Bishop J.M., Coffin J., Fleissner E., Goff S.P., Oroszlan S., Robinson H., Skalka A.M., Temin H.M., Vogt. V.M. Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. l988;62:1808–1890. [PMC free article: PMC253234] [PubMed: 3357211]
  145. Linial M.L., Miller A.D. Retroviral RNA packaging: Sequence requirements and implications. Curr. Top. Microbiol. Immunol. 1990;157:125–152. [PubMed: 2394131]
  146. Lopez S., Yao J.S., Kuhn R.J., Strauss E.G., Strauss J.H. Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J. Virol. 1994;68:1316–1323. [PMC free article: PMC236585] [PubMed: 7508993]
  147. Love D.N., Weiss R. Pseudotypes of vesicular stomatitis virus determined by exogenous and endogenous avian RNA tumor viruses. Virology. 1974;57:271–278. [PubMed: 4362025]
  148. Lu Y.L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 1993;67:6542–6550. [PMC free article: PMC238091] [PubMed: 8411357]
  149. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 1993;73:1067–1078. [PubMed: 8513493]
  150. Mak J., Jiang M., Wainberg M.A., Hammarskjold M.L., Rekosh D., Kleiman L. Role of Pr160gag-pol in mediating the selective incorporation of tRNA-Lys into human immunodeficiency virus type 1 particles. J. Virol. 1994;68:2065–2072. [PMC free article: PMC236680] [PubMed: 7511167]
  151. Mammano F., Ohagen A., Höglund S., Göttlinger H.G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 1994;68:4927–4936. [PMC free article: PMC236433] [PubMed: 8035491]
  152. Massiah M.A., Starich M.R., Paschall C.M., Summers M.F., Christensen A.M., Sundquist W.I. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 1994;244:198–223. [PubMed: 7966331]
  153. Matthews S., Barlow P., Boyd J., Barton G., Russell R., Mills H., Cunningham M., Meyers N., Burns N., Clark N., Kingsman S., Kingsman A., Campbell I. Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ Nature. 1994;370:666–668. [PubMed: 8065455]
  154. McNally M.T., Gontarek R., Beemon K. Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology. 1991;185:99–108. [PubMed: 1656608]
  155. Mellon P., Duesberg P.H. Subgenomic cellular Rous sarcoma virus RNAs contain oligonucleotides form the 3′ and the 5′ terminus of virion RNA. Nature. 1977;270:631–634. [PubMed: 201866]
  156. Méric C., Darlix J.-L., Spahr P.-F. It is Rous sarcoma virus protein p12 and not p19 that binds tightly to Rous sarcoma virus RNA. J. Mol. Biol. 1984;173:531–538. [PubMed: 6323722]
  157. Méric C., Gouilloud E., Spahr P.-F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): Deletions of Cys-His boxes. J. Virol. 1988;62:3328–3333. [PMC free article: PMC253454] [PubMed: 2841485]
  158. Meyers G., Tautz N., Dubovi E.J., Thiel H.-J. Viral cyopathogenicity correlated with integration of ubiquitin-coding sequences. Virology. 1991;180:602–616. [PMC free article: PMC7172395] [PubMed: 1846490]
  159. Moelling K., Bolognesi D.P., Bauer H., Busen W., Plassmann H.W., Hausen P. Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat. New Biol. 1971;234:240–243. [PubMed: 4331605]
  160. Momany C., Kovari L.c., Prongay A.J., Keller W., Gitti R.K., Lee B.M., Gorbalenya A.E., Tong L., McClure J., Ehrlich L.S., Summers M.F., Carter C., Rossmann M.G. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 1996;3:763–770. [PubMed: 8784350]
  161. Morellet N., Jullian N., De Rocquigny H., Maigret B., Darlix J.-L., Roques B.P. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J. 1992;11:3059–3065. [PMC free article: PMC556789] [PubMed: 1639074]
  162. Murphy F.A., Fauquet C.M., Bishop D.H.L., Ghabrial S.A., Jarvis A.W., Martelli G.P., Mayo M.A., Summers M.D. 1995Virus taxonomy: Sixth Report of the International Committee on the Taxonomy of Viruses Springer Verlag, New York.
  163. Nagy K., Young M., Baboonian C., Merson J., Whittle P., Oroszlan S. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: Evidence for a role of protease in the early phase. J. Virol. 1994;68:757–765. [PMC free article: PMC236512] [PubMed: 8289379]
  164. Navia M.A., Fitzgerald P.M.D., McKeever B.M., Leu C.-T., Heimbach J.C., Herber W.K., Sigal I.S., Darke P.L., Springer J.P. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature. 1989;337:615–620. [PubMed: 2645523]
  165. Nermut M.V., Frank H., Schafer W. Properties of mouse leukemia viruses. III. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology. 1972;49:345–358. [PubMed: 4115401]
  166. Nermut M.V., Grief C., Hashmi S., Hockley D.J. Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. Aids Res. Hum. Retroviruses. 1993;9:929–938. [PubMed: 8280478]
  167. Nermut M.V., Hockley D.J., Jowett J.B.M., Jones I.M., Garreau M., Thomas D. Fullerene-like organization of HIV gag protein shell in virus-like particles produced by recombinant baculovirus. Virology. 1994;198:288–296. [PubMed: 8259664]
  168. Oertle S., Spahr P.F. Role of the Gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA. J. Virol. 1990;64:5757–5763. [PMC free article: PMC248723] [PubMed: 1700822]
  169. Oppermann H., Bishop J.M., Varmus H.E., Levintow L. A joint product of the genes gag and pol of avian sarcoma virus: A possible precursor of reverse transcriptase. Cell. 1977;12:993–1005. [PubMed: 74287]
  170. Ott D., Rein A. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J. Virol. 1992;66:4632–4638. [PMC free article: PMC241286] [PubMed: 1321266]
  171. Ott D.E., Coren L.V., Kane B.P., Busch L.K., Johnson D.G., Sowder II R.C., Chertova E.N., Arthur L.O., Henderson L.E. Cytoskeletal proteins inside human immunodeficiency virus type-1 virions. J. Virol. 1996;70:7734–7743. [PMC free article: PMC190843] [PubMed: 8892894]
  172. Palmiter R.D., Gagnon J., Vogt V.M., Ripley S., Eisenman R. The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag). Virology. 1978;91:432–433. [PubMed: 217156]
  173. Panganiban A.T., Temin H.M. The retrovirus pol gene encodes a product required for DNA integration: Identification of a retrovirus int locus. Proc. Natl. Acad. Sci. 1984;81:7885–7889. [PMC free article: PMC392257] [PubMed: 6083562]
  174. Papsidero L.D., Sheu M., Ruscetti F.W. Human immunodeficiency virus type 1 neutralizing monoclonal antibodies which react with p17 core protein: Characterization and epitope mapping. J. Virol. 1989;63:267–272. [PMC free article: PMC247681] [PubMed: 2462060]
  175. Parent L.J., Bennett R.P., Craven R.C., Nelle T.D., Krishna N.K., Bowzard J.B., Wilson C.B., Puffer B.A., Montelaro R.C., Wills J.W. Positionally independent and exchangeable late budding functions of the RSV and HIV Gag proteins. J. Virol. 1995;69:5455–5460. [PMC free article: PMC189393] [PubMed: 7636991]
  176. Paxton W., Connor R.I., Landau N.R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 1993;67:7229–7237. [PMC free article: PMC238185] [PubMed: 8230445]
  177. Pepinsky R.B., Vogt V.M. Identification of retrovirus matrix proteins by lipid-protein crosslinking. J. Mol. Biol. 1979;131:819–839. [PubMed: 229234]
  178. Pepinsky R.B., Vogt V.M. Fine structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of avian sarcoma and leukemia viruses by cyanogen bromide mapping. J. Virol. 1984;52:145–153. [PMC free article: PMC254500] [PubMed: 6090691]
  179. Pepinsky R.B., Mattaliano R.J., Vogt V.M. Structure and processing of the p2 region of avian sarcoma and leukemia virus gag precursor polyproteins. J. Virol. 1986;58:50–58. [PMC free article: PMC252875] [PubMed: 3005658]
  180. Pepinsky R.B., Papayannopoulos I.A., Campbell S., Vogt V.M. Analysis of Rous sarcoma virus Gag proteins by mass spectrometry indicates trimming by host exopeptidase. J. Virol. 1996;70:3313–3318. [PMC free article: PMC190200] [PubMed: 8627817]
  181. Pepinsky R.B., Papayannopoulos I.A., Chow E.P., Krishna N.K., Craven R.C., Vogt V.M. Differential proteolytic processing leads to multiple forms of the CA protein of avian sarcoma and leukemia viruses. J. Virol. 1995;69:6430–6438. [PMC free article: PMC189543] [PubMed: 7666544]
  182. Perez L.G., Davis G.L., Hunter E. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: Analysis of intracellular transport and assembly into virions. J. Virol. 1987;61:2981–2988. [PMC free article: PMC255870] [PubMed: 3041017]
  183. Peters G.G., Hu J. Reverse transcriptase as the major determinant for selective packaging of tRNAs into avian sarcoma virus particles. J. Virol. 1980;33:692–700. [PMC free article: PMC353697] [PubMed: 6162035]
  184. Pettit S.C., Simsic J., Loeb D.D., Everitt L., Hutchison III C.A., Swanstrom R. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 1991;266:14539–14547. [PubMed: 1860860]
  185. Pettit S.C., Moody M.D., Wehbie R.S., Kaplan A.H., Nantermet P.V., Klein C.A., Swanstrom R. The p2 domain of human immunodeficiency virus type 1 gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 1994;68:8017–8027. [PMC free article: PMC237265] [PubMed: 7966591]
  186. Pinter A., Honnen W.J. O-linked glycosylation of retroviral envelope gene products. J. Virol. 1988;62:1016–1021. [PMC free article: PMC253661] [PubMed: 2828650]
  187. Poorman R.A., Tomasselli A.G., Heinrikson R.L., Kézdy F.J. A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J. Biol. Chem. 1991;266:14554–14561. [PubMed: 1860861]
  188. Prats A.-C., Sarin L., Gabus C., Litvak S., Keith G., Darlix J.-L. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 1988;7:1777–1783. [PMC free article: PMC457168] [PubMed: 2458920]
  189. Prats A.-C., Roy C., Wang P., Erard M., Housset V., Gabus C., Paoletti C., Darlix J.-L. cis Elements and trans-acting factors involved in dimer formation of murine leukemia virus RNAs. J. Virol. 1990;64:774–783. [PMC free article: PMC249172] [PubMed: 2153242]
  190. Putterman D., Pepinsky T.B., Vogt. V.M. Ubiquitin in avian sarcoma and leukemia virus particles. Virology. l990;176:633–637. [PubMed: 2161153]
  191. Pyra H., Boni J., Schupbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc. Natl. Acad. Sci. 1994;91:1544–1548. [PMC free article: PMC43196] [PubMed: 7509077]
  192. Quade K., Smith R.E., Nichols J.L. Evidence for common nucleotide sequences in the RNA subunits comprising Rous sarcoma virus 70S RNA. Virology. 1974;61:287–291. [PubMed: 4370009]
  193. Quigley J.P., Rifkin D.B., Reich R. Phospholipid compostion of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology. 1971;46:106–116. [PubMed: 4108030]
  194. Rao A., Belyaev A.S., Fry E., Roy P., Jones I.M., Stuart D.I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature. 1995;378:743–747. [PubMed: 7501025]
  195. Rein A. Interference grouping of murine leukemia viruses: A distinct receptor for MCF-recombinant viruses in mouse cells. Virology. 1982;120:251–257. [PubMed: 6285602]
  196. Rein A., McClure M.R., Rice N.R., Luftig R.B., Schultz A.M. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. 1986;83:7246–7250. [PMC free article: PMC386692] [PubMed: 3489936]
  197. Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 1994;68:1773–1781. [PMC free article: PMC236638] [PubMed: 8107239]
  198. Rey O., Canon J., Krogstad P. HIV-1 Gag protein associates with F-actin to microfilaments. Virology. 1996;220:530–534. [PubMed: 8661406]
  199. Rhee S.S., Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 1987;61:1046–1053. [PMC free article: PMC254061] [PubMed: 3493352]
  200. Rhee S.S., Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell. 1990;63:77–86. [PubMed: 2170021]
  201. Rice P., Mizuuchi K. Structure of the bacteriophage Mu transposase core: A common structural motif for DNA transposition and retroviral integration. Cell. 1995;82:209–220. [PubMed: 7628012]
  202. Rifkin D.B., Compans R.W. Identification of the spike proteins of Rous sarcoma virus. Virology. 1971;46:485–489. [PubMed: 4108619]
  203. Roberts M.M., Oroszlan S. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem. Biophys. Res. Commun. 1989;160:486–494. [PubMed: 2541703]
  204. Roberts M.M., Copeland T.D., Oroszlan. S. In situ processing of a retroviral nucleocapsid protein by the viral proteinase. Protein Eng. 1991;4:695–700. [PubMed: 1658777]
  205. Sakalian M., Parker S.D., Weldon R.A. Jr., Hunter E. Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. J. Virol. 1996;70:3706–3715. [PMC free article: PMC190246] [PubMed: 8648705]
  206. Sarkar N.H., Nowinski R.C., Moore D.H. Helical nucleocapsid structure of the oncogenic ribonucleic acid viruses (oncornaviruses). J. Virol. 1971;8:564–572. [PMC free article: PMC376229] [PubMed: 4108573]
  207. Schiff-Maker L., Rosenberg N. gag-Derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells. Virology. 1986;154:286–301. [PubMed: 3020782]
  208. Schmidt M.F.G. Fatty acylation of proteins. Biochim. Biophys. Acta. 1989;988:411–426. [PMC free article: PMC7148804] [PubMed: 2686758]
  209. Schwartz D.E., Tizard R., Gilbert W. Nucleotide sequence of Rous sarcoma virus. Cell. 1983;32:853–869. [PubMed: 6299578]
  210. Schwartz O., Maréchal V., Danos O., Heard J.-M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 1995;69:4053–4059. [PMC free article: PMC189139] [PubMed: 7539505]
  211. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. 1983;80:618–3622. [PMC free article: PMC394101] [PubMed: 6304725]
  212. Shank P.R., Hughes S.E., Kung H.-J., Majors J.E., Quintrell N., Guntaka R.V., Bishop J.M., Varmus H.E. Mapping unintegrated avian sarcoma virus DNA: Termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell. 1978;15:1383–1395. [PubMed: 215324]
  213. Shinnick T.M., Lerner R.A., Sutcliffe J.G. Nucleotide sequence of Moloney murine leukemia virus. Nature. 1981;293:543–548. [PubMed: 6169994]
  214. Sommerfelt M.A., Rhee S.S., Hunter E. Importance of the p12 protein in Mason-Pfizer monkey virus assembly and infectivity. J. Virol. 1992;66:7005–7011. [PMC free article: PMC240351] [PubMed: 1433505]
  215. Song S.U., Gerasimova T., Kurkulos M., Boeke J.D., Corces V.G. An Env-like protein encoded by a Drosophila retroelement: Evidence that gypsy is an infectious retrovirus. Genes Dev. 1994;8:2046–2057. [PubMed: 7958877]
  216. Spearman P., Ratner L. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates. J. Virol. 1996;70:8187–8194. [PMC free article: PMC190900] [PubMed: 8892951]
  217. Steeg C.M., Vogt V.M. RNA binding properties of MA protein (p19gag) of avian sarcoma and leukemia viruses. J. Virol. l990;64:847–855. [PMC free article: PMC249180] [PubMed: 2153248]
  218. Stewart L., Vogt V.M. trans-Acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase. J. Virol. 1991;65:6218–6231. [PMC free article: PMC250316] [PubMed: 1717719]
  219. Stewart L., Schatz G., Vogt V.M. Properties of avian retrovirus particles defective in viral protease. J. Virol. l990;64:5076–5092. [PMC free article: PMC248000] [PubMed: 1697912]
  220. Strambio de Castillia C., Hunter E. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 1992;66:7021–7032. [PMC free article: PMC240357] [PubMed: 1279197]
  221. Stromberg K., Hurley N.E., Davis N.L., Rueckert R.R., Fleissner E. Structural studies of avian myeloblastosis virus: Comparison of polypeptides in virion and core component by dodecyl sulfate polyacrylamide gel electrophoresis. J. Virol. 1974;13:513–528. [PMC free article: PMC355323] [PubMed: 4129794]
  222. Subbramanian R.A., Cohen E.A. Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 1994;68:6831–6835. [PMC free article: PMC237118] [PubMed: 7933064]
  223. Summers M.F., Henderson L.E., Chance M.R., Bess J.W. Jr., South T.L., Blake P.R., Sagi I., Perez-Alvarado G., Sowder R.C. III, Hare D.R., Arthur L.O. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1992;1:563–574. [PMC free article: PMC2142235] [PubMed: 1304355]
  224. Swain A., Coffin J.M. Polyadenylation at correct sites in genome RNA is not required for retrovirus replication or genome encapsidation. J. Virol. 1989;63:3301–3306. [PMC free article: PMC250902] [PubMed: 2473216]
  225. Tanese N., Goff S.P. Domain structure of the Moloney murine leukemia virus reverse transcriptase: Mutational analyses and separate expression of the DNA polymerase and RNaseH activities. Proc. Natl. Acad. Sci. 1988;85:1777–1781. [PMC free article: PMC279862] [PubMed: 2450347]
  226. Temin H.M., Mizutani S. RNA-directed DNA polymerase in virions of Rous sarcoma virus. Nature. 1970;226:1211–1213. [PubMed: 4316301]
  227. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Göttlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature. 1994;372:363–365. [PubMed: 7969495]
  228. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., Perry S.T., Rushlow K.E., Le Grice S.F., Payne S.L. Characterization of equine infectious anemia virus dUTPase: Growth properties of a dUPTase-deficient mutant. J. Virol. 1993;67:2592–2600. [PMC free article: PMC237580] [PubMed: 8386267]
  229. Trono D. HIV accessory proteins: Leading roles for the supporting case. Cell. 1995;82:189–192. [PubMed: 7628010]
  230. van Zaane D., Gielkens A.L.J., Dekker-Michielsen M.J.A., Bloemers H.P.J. Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology. 1975;67:544–552. [PubMed: 1189288]
  231. Vaux D.J.T., Helenius A., Mellman I. Spike-nucleocapsid interaction in Semliki forest virus reconstructed using network antibodies. Nature. 1988;336:36–42. [PubMed: 2460771]
  232. Verma I.M., Meuth N.L., Fan H., Baltimore D. Covalently linked RNA-DNA molecule as initial product of the RNA tumor virus DNA polymerase. Nat. New Biol. 1971;223:131–134. [PubMed: 4330073]
  233. Vogt V.M. Proteolysis and particle maturation. Curr. Top. Microbiol. Immunol. 1996;214:95–132. [PubMed: 8791726]
  234. Vogt V.M., Eisenman R. Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc. Natl. Acad. Sci. 1973;70:1734–1738. [PMC free article: PMC433584] [PubMed: 4352653]
  235. von der Helm K. Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15. Proc. Natl. Acad. Sci. 1977;74:911–915. [PMC free article: PMC430528] [PubMed: 191840]
  236. von Schwedler U., Kornbluth R.S., Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. 1994;91:6992–6996. [PMC free article: PMC44324] [PubMed: 8041734]
  237. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 1993;67:4945–4955. [PMC free article: PMC237882] [PubMed: 8331734]
  238. Wang L.-H., Duesberg P., Beemon K., Vogt P.K. Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: Sarcoma specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly (A) end. J. Virol. 1975;16:1051–1070. [PMC free article: PMC354767] [PubMed: 170411]
  239. Weiss S.R., Varmus H.E., Bishop J.M. The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukemia viruses. Cell. 1977;12:983–992. [PubMed: 202396]
  240. Weldon R.J., Wills J.W. Characterizaton of a small (25 kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 1993;67:5550–5561. [PMC free article: PMC237958] [PubMed: 8394460]
  241. Welker R., Kottler H., Kalbitzer H.R., Kräusslich H.-G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 1996;219:228–236. [PubMed: 8623533]
  242. Wilk T., Pfeiffer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 1992;189:167–177. [PubMed: 1604808]
  243. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 1992;66:7193–7200. [PMC free article: PMC240416] [PubMed: 1433512]
  244. Wills J.W., Craven R.C. Form function and use of retroviral Gag proteins. AIDS. 1991;5:639–654. [PubMed: 1883539]
  245. Wills J.W., Craven R.C., Weldon R.A. Jr., Nelle T.D., Erdie C.R. Suppression of retroviral MA deletions by the amino-terminal membrane binding domain of p60src. J. Virol. 1991;65:3804–3812. [PMC free article: PMC241411] [PubMed: 1710290]
  246. Wlodawer A., Miller M., Jaskolski M., Sathyannrayana B.K., Baldwin E., Weber I.T., Selk L.M., Clawson L., Schneider J., Kent S.B.H. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease. Science. 1989;245:616–621. [PubMed: 2548279]
  247. Xiong Y., Eickbush T.H. Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 1990;9:3353–3362. [PMC free article: PMC552073] [PubMed: 1698615]
  248. Yoshinaka S., Katoh I., Copeland T.D., Oroszlan S. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc. Natl. Acad. Sci. 1985;82:1618–1622. [PMC free article: PMC397323] [PubMed: 3885215]
  249. Yoshinaka Y., Luftig R.B. Murine leukemia virus morphogenesis: Cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand (“immature”) to a collapsed (“mature”) form of the virus core. Proc. Natl. Acad. Sci. 1977;74:3446–3450. [PMC free article: PMC431601] [PubMed: 410020]
  250. Young J.A.T., Bates P., Willert K., Varmus H.E. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science. 1990;250:1421–1423. [PubMed: 2175047]
  251. Yu S.F., Baldwin D.N., Gwynn S.R., Yendapalli S., Linial M.L. Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science. 1996;271:1579–1582. [PubMed: 8599113]
  252. Yu X., Yuan X., Masuda Z., Lee T.H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 1992;66:4966–4971. [PMC free article: PMC241345] [PubMed: 1629961]
  253. Zavada J. Pseudotypes of vesicular stomatitis virus with the coat of murine leukemia virus and of avian myeloblastosis virus. J. Gen. Virol. 1972;125:183–191. [PubMed: 4339183]
  254. Zhao X., Fox J.M., Olson N.H., Baker T.S., Young M.J. In vitro assembly of cowpea chlorotic virus from coat protein expressed in E. coli and in vitro transcribed viral cDNA. Virology. 1995;207:486–494. [PubMed: 7886952]
  255. Zhou W., Resh M.D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. (in press). 1996 [PMC free article: PMC190946] [PubMed: 8970978]
  256. Zhou W., Parent L.J., Wills J.W., Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 1994;68:2556–2569. [PMC free article: PMC236733] [PubMed: 8139035]